Furthermore, among the seven markers (CD13, CD24, CD44, CD90, CD133, EPCAM and ALDH1A1)27 of cancer stem cells (CSCs) in HCC, five were downregulated after cFAM210A overexpression (Fig. 5g). The gene discussed is CD44; the disease is hepatocellular carcinoma.